Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.


Sub-classes under this class:

Class Number Class Name Patents
424/275.1 Allergen or component thereof (e.g., ragweed pollen, etc.) 214
424/185.1 Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same 1,991
424/234.1 Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) 1,162
424/277.1 Cancer cell or component thereof 426
424/203.1 Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) 226
424/202.1 Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) 222
424/201.1 Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) 147
424/193.1 Conjugate or complex 918
424/274.1 Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) 103
424/192.1 Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) 1,093
424/198.1 Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof 519
424/265.1 Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) 278
424/200.1 Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof 262
424/199.1 Recombinant virus encoding one or more heterologous proteins or fragments thereof 642
424/204.1 Virus or component thereof 1,086


Patents under this class:

Patent Number Title Of Patent Date Issued
7618942 Method of using broad-spectrum delta-endotoxins Nov. 17, 2009
7618641 Functionally reconstituted viral membranes containing adjuvant Nov. 17, 2009
7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use Nov. 10, 2009
7615228 Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits Nov. 10, 2009
7615226 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant Nov. 10, 2009
7615222 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same Nov. 10, 2009
7612172 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer Nov. 3, 2009
7612038 Biglycan and related therapeutics and methods of use Nov. 3, 2009
7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositions Nov. 3, 2009
7608277 Tuberculosis nucleic acids, polypeptides and immunogenic compositions Oct. 27, 2009
7608276 Staphylococcus aureus proteins and nucleic acids Oct. 27, 2009
7608247 Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation Oct. 27, 2009
7608246 Apolipoprotein E as an adjuvant for lipid antigens Oct. 27, 2009
7605121 Oligopeptide lyophilisate, their preparation and use Oct. 20, 2009
7604810 Conserved Neisserial antigens Oct. 20, 2009
7604809 Reinforcing systemic immune responses with lactobacillus casei Oct. 20, 2009
7604804 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120 Oct. 20, 2009
7604803 Method to enhance an immune response of nucleic acid vaccination Oct. 20, 2009
7604802 Method of obtaining cellular immune responses from proteins Oct. 20, 2009
7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins Oct. 13, 2009
7601358 Mycobacterium tuberculosis protein composition Oct. 13, 2009
7601357 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment Oct. 13, 2009
7601355 Compositions and methods for altering immune function Oct. 13, 2009
7597896 Composition comprising a protein encoded by a modified ERP gene of Mycobacterium Oct. 6, 2009
7597895 Signal peptides, nucleic acid molecules and methods for treatment of caries Oct. 6, 2009
7595060 Yeast-antigen compositions methods of making the same Sep. 29, 2009
7595057 Streptococcus pyogenes antigens and corresponding DNA fragments Sep. 29, 2009
7592421 HLA class II peptide mimics Sep. 22, 2009
7592158 BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses Sep. 22, 2009
7592135 High resolution typing system for pathogenic Mycobacterium tuberculosum Sep. 22, 2009
7592011 Genes and proteins, and their use Sep. 22, 2009
7592009 Polypeptide ligands for targeting cartilage and methods of use thereof Sep. 22, 2009
7592008 Membrane scaffold proteins Sep. 22, 2009
7591997 Method for determining the susceptibility of a subject to infection Sep. 22, 2009
7589174 GRP94-based compositions and methods of use thereof Sep. 15, 2009
7588774 Molecules enhancing dermal delivery of influenza vaccines Sep. 15, 2009
7588773 Methods and compositions for diagnosing and preventing a group B streptococcal infection Sep. 15, 2009
7588772 AAV capsid library and AAV capsid proteins Sep. 15, 2009
7588770 Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins Sep. 15, 2009
7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Sep. 15, 2009
7588763 Methods for the prevention against or treatment of diabetes with ETXB and/or insulin Sep. 15, 2009
7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy Sep. 8, 2009
7585510 Vaccine Sep. 8, 2009
7585509 Erb-2 receptor targeting peptide Sep. 8, 2009
7585506 Compositions and methods for the therapy and diagnosis of lung cancer Sep. 8, 2009
7582304 Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans Sep. 1, 2009
7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness Sep. 1, 2009
7579012 Targeting of triacylglycerol synthase gene for tuberculosis treatment Aug. 25, 2009
7579010 Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin Aug. 25, 2009
7579009 Whole bacterial cells as immune modulator Aug. 25, 2009



 
 
  Recently Added Patents
Caching digital image data
Flashlight with rotatable handle
Authentication of identification documents
Method of monitoring the communication in a network
Measuring instrument for gravimetric moisture determination
Metal powder for electrically conductive paste and electrically conductive paste
Tools for femoral resection in knee surgery
  Randomly Featured Patents
Flame ashing process and apparatus for stripping photoresist
Combined yard hydrant and head with removable cap
Boat loader
Process for producing a gas which can be substituted for natural gas
Electrical control unit for an automobile
Stackable container
Rotary encoder and input device using the same
Plaque or the like
Self-compensating hose coupling
Particulate preparation containing a flourracil derivative and hydroxypropylmethyl-cellulose